Topics

FDA Approves New Drug Option for Acute Migraine

11:49 EDT 11 Oct 2019 | Medscape

The US Food and Drug Administration has approved Reyvow (lasmiditan) tablets for acute migraine with or without aura in adults.
FDA Approvals

Original Article: FDA Approves New Drug Option for Acute Migraine

NEXT ARTICLE

More From BioPortfolio on "FDA Approves New Drug Option for Acute Migraine"

Quick Search

Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...